Uncategorized

Mirum Pharmaceuticals Presents LIVMARLI Clinical Data and Real-World Evidence at NASPGHAN

Mirum Pharmaceuticals, Inc. announced the presentation of a series of analyses demonstrating further benefit of LIVMARLI® oral solution in patients with cholestatic pruritus associated with Alagille syndrome and for patients with progressive familial intrahepatic cholestasis, two rare debilitating liver diseases.

Mirum Pharmaceuticals Presents LIVMARLI Clinical Data and Real-World Evidence at NASPGHAN Read More »

Scroll to Top